Picture of Asia Green Biotechnology logo

ASIA Asia Green Biotechnology Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+199.04%
3m+44.26%
6m+34.39%
1yr-43.62%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Asia Green Biotechnology EPS forecast chart

Profile Summary

Asia Green Biotechnology Corp. is a Canada-based early-stage international agro-technology company. The Company is focused on the development, evaluation, testing, application and, ultimately, supply to the market of organic hybridization technology and certain products derived from that technology (the Technology). The Company is engaged in planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of the license agreement with InPlanta Biotechnology Inc. (InPlanta) and the evaluation and development of medicinal and related cannabinoid extracts under the terms of license agreements with Swysh Inc. (Swysh), and Pathway Rx Corp (Pathway Rx). It is in the process of establishing and implementing research and development programs in Cambodia and Thailand and continues to evaluate the potential to expand its business operations to other countries in the region.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    December 19th, 2017
    Public Since
    January 24th, 2019
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    36,247,100
    Blurred out image of a map
    Address
    707 - 7th Avenue SW, Suite 1150, Calgary, T2P 3H6
    Web
    http://asiacannabiscorp.com/
    Phone
    +1 4036125655
    Auditors
    Paul J. Rozek Professional Corporation

    ASIA Share Price Performance

    Upcoming Events for ASIA

    Asia Green Biotechnology Corp Annual Shareholders Meeting

    Similar to ASIA

    Picture of 1933 Industries logo

    1933 Industries

    ca flag iconCanadian Securities Exchange

    Picture of 1CM logo

    1CM

    ca flag iconCanadian Securities Exchange

    Picture of Acreage Holdings logo

    Acreage Holdings

    ca flag iconCanadian Securities Exchange

    Picture of Adastra Holdings logo

    Adastra Holdings

    ca flag iconCanadian Securities Exchange

    Picture of Aion Therapeutic logo

    Aion Therapeutic

    ca flag iconCanadian Securities Exchange

    FAQ